BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Rhee JK, Lee S, Park WY, Kim YH, Kim TM. Allelic imbalance of somatic mutations in cancer genomes and transcriptomes. Sci Rep 2017;7:1653. [PMID: 28490743 DOI: 10.1038/s41598-017-01966-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
2 Yu L, Shang D, Lang L, Liu Y, Yu M, Song D, Jia S, Han S, Li C, Liu J, Xu Y, Zhang X. TMF, a natural dihydroflavonoid isolated from Scutellaria javanica Jungh, stimulates anticancer activity of s180 cancer-bearing mice, induces apoptosis, inhibits invasion and migration on HepG-2 cells. J Ethnopharmacol 2020;263:113072. [PMID: 32738393 DOI: 10.1016/j.jep.2020.113072] [Reference Citation Analysis]
3 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am. 2013;42:261-284. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
4 Zarrilli G, Angerilli V, Cappellesso R, Galuppini F, Pennelli G, Farinati F, Nicolè L, Savarino E, Realdon S, Griguolo G, Bottosso M, Dieci MV, Guarneri V, Tos APD, Mele ML, Fassan M. Gastric metastases of breast cancer: histopathological and molecular characterization of a single Institution case series. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153872] [Reference Citation Analysis]
5 Zhuang MK, Chen FL. Biomarkers of epithelial-mesenchymal transition in gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3204-3210 [DOI: 10.11569/wcjd.v21.i30.3204] [Reference Citation Analysis]
6 Molinari C, Abou Khouzam R, Salvi S, Rossi T, Ranzani GN, Calistri D. Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR. J Vis Exp 2018. [PMID: 29443099 DOI: 10.3791/57066] [Reference Citation Analysis]
7 Hasan S. An Overview of Promising Biomarkers in Cancer Screening and Detection. Curr Cancer Drug Targets 2020;20:831-52. [PMID: 32838718 DOI: 10.2174/1568009620666200824102418] [Reference Citation Analysis]
8 Bracey TS, Keers LC, Adams SA, Smith ME. Diffuse Gastric Carcinoma Undergoes Characteristic Phenotypic Changes in the Intravascular Environment: Evidence for a Reversal of the Epithelial-Mesenchymal Transition in Lymphovascular Metastasis. Int J Surg Pathol 2017;25:222-9. [PMID: 27733664 DOI: 10.1177/1066896916672331] [Reference Citation Analysis]
9 Park SY, Yoon S, Sun EG, Zhou R, Bae JA, Seo YW, Chae JI, Paik MJ, Ha HH, Kim H, Kim KK. Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex. Int J Mol Sci 2017;18:E2601. [PMID: 29207493 DOI: 10.3390/ijms18122601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Ramos MFKP, Pereira MA, de Mello ES, Cirqueira CDS, Zilberstein B, Alves VAF, Ribeiro-Junior U, Cecconello I. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery. World J Clin Oncol 2021;12:688-701. [PMID: 34513602 DOI: 10.5306/wjco.v12.i8.688] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Regalo G, Förster S, Resende C, Bauer B, Fleige B, Kemmner W, Schlag PM, Meyer TF, Machado JC, Leutz A. C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation. J Mol Med (Berl) 2016;94:1385-95. [PMID: 27522676 DOI: 10.1007/s00109-016-1447-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Sonoshita M, Cagan RL. Modeling Human Cancers in Drosophila. Curr Top Dev Biol 2017;121:287-309. [PMID: 28057303 DOI: 10.1016/bs.ctdb.2016.07.008] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 13.8] [Reference Citation Analysis]
13 Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
14 Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
15 Molinaro V, Pensotti V, Marabelli M, Feroce I, Barile M, Pozzi S, Laghi L, Serrano D, Bernard L, Bonanni B, Ranzani GN. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Genes Chromosomes Cancer 2014;53:432-45. [PMID: 24493355 DOI: 10.1002/gcc.22155] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
16 Liu B, Ma X, Ha W. Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer. Front Genet 2022;12:827444. [DOI: 10.3389/fgene.2021.827444] [Reference Citation Analysis]
17 Jiang J, Shen S, Dong N, Liu J, Xu Q, Sun L, Yuan Y. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med 2018;7:4068-76. [PMID: 29963765 DOI: 10.1002/cam4.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Beetham H, Chen A, Telford BJ, Single A, Jarman KE, Lackovic K, Luxenburger A, Guilford P. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Sci Rep 2019;9:12511. [PMID: 31467357 DOI: 10.1038/s41598-019-48929-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Figueiredo C, Garcia-Gonzalez MA, Machado JC. Molecular pathogenesis of gastric cancer. Helicobacter. 2013;18 Suppl 1:28-33. [PMID: 24011242 DOI: 10.1111/hel.12083] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
21 Pryczynicz A, Guzińska-Ustymowicz K, Niewiarowska K, Cepowicz D, Kemona A. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Tumour Biol. 2014;35:6587-6592. [PMID: 24696260 DOI: 10.1007/s13277-014-1855-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
22 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wu Y, Kanchanawong P, Zaidel-Bar R. Actin-delimited adhesion-independent clustering of E-cadherin forms the nanoscale building blocks of adherens junctions. Dev Cell 2015;32:139-54. [PMID: 25600236 DOI: 10.1016/j.devcel.2014.12.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 16.9] [Reference Citation Analysis]
24 Chiurillo MA. Role of gene polymorphisms in gastric cancer and its precursor lesions: Current knowledge and perspectives in Latin American countries. World J Gastroenterol 2014; 20(16): 4503-4515 [PMID: 24782603 DOI: 10.3748/wjg.v20.i16.4503] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
25 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
26 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Amorim I, Taulescu MA, Day MJ, Catoi C, Reis CA, Carneiro F, Gärtner F. Canine Gastric Pathology: A Review. J Comp Pathol 2016;154:9-37. [PMID: 26774560 DOI: 10.1016/j.jcpa.2015.10.181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
28 Sanches JM, Figueiredo J, Fonseca M, Durães C, Melo S, Esménio S, Seruca R. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet 2015;23:1072-9. [PMID: 25388006 DOI: 10.1038/ejhg.2014.240] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
29 Pohjanen VM, Koivurova OP, Mäkinen JM, Karhukorpi JM, Joensuu T, Koistinen PO, Valtonen JM, Niemelä SE, Karttunen RA, Karttunen TJ. Interleukin 6 gene polymorphism -174 is associated with the diffuse type gastric carcinoma. Genes Chromosomes Cancer 2013;52:976-82. [PMID: 23893709 DOI: 10.1002/gcc.22093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
30 Baj J, Korona-Głowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells 2020;9:E1055. [PMID: 32340207 DOI: 10.3390/cells9041055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
31 Sgouras D, Tegtmeyer N, Wessler S. Activity and Functional Importance of Helicobacter pylori Virulence Factors. Adv Exp Med Biol 2019;1149:35-56. [PMID: 31016624 DOI: 10.1007/5584_2019_358] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
32 Smyth EC, Gambardella V, Cervantes A, Fleitas T. Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy. Ann Oncol 2021;32:590-9. [PMID: 33609722 DOI: 10.1016/j.annonc.2021.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
33 Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer. 2014;13:258. [PMID: 25431208 DOI: 10.1186/1476-4598-13-258] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
34 Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
35 Garrido VT, Banerjee S. E-Cadherin: An Enigma in Pancreatic Diseases. Cell Mol Gastroenterol Hepatol 2020;9:191-2. [PMID: 31678202 DOI: 10.1016/j.jcmgh.2019.10.004] [Reference Citation Analysis]
36 Mestre T, Figueiredo J, Ribeiro AS, Paredes J, Seruca R, Sanches JM. Quantification of topological features in cell meshes to explore E-cadherin dysfunction. Sci Rep 2016;6:25101. [PMID: 27151223 DOI: 10.1038/srep25101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
37 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ozawa M, Kobayashi W. Cadherin cytoplasmic domains inhibit the cell surface localization of endogenous E-cadherin, blocking desmosome and tight junction formation and inducing cell dissociation. PLoS One 2014;9:e105313. [PMID: 25121615 DOI: 10.1371/journal.pone.0105313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
39 Wang J, Liu Q, Xiao H, Luo X, Liu X. Suppressive effects of Momordin Ic on HepG2 cell migration and invasion by regulating MMP-9 and adhesion molecules: Involvement of p38 and JNK pathways. Toxicology in Vitro 2019;56:75-83. [DOI: 10.1016/j.tiv.2019.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
40 Wang J, Ma Y, Guo M, Yang H, Guan X. Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells. Cytotechnology 2021;73:49-61. [PMID: 33505113 DOI: 10.1007/s10616-020-00441-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Beishline K, Azizkhan-Clifford J. Sp1 and the 'hallmarks of cancer'. FEBS J 2015;282:224-58. [PMID: 25393971 DOI: 10.1111/febs.13148] [Cited by in Crossref: 253] [Cited by in F6Publishing: 234] [Article Influence: 36.1] [Reference Citation Analysis]
42 Lee J, Kim KE, Cheon S, Song JH, Houh Y, Kim TS, Gil M, Lee KJ, Kim S, Kim D, Hur DY, Yang Y, Bang SI, Park HJ, Cho D. Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin. Oncotarget 2016;7:65825-36. [PMID: 27589563 DOI: 10.18632/oncotarget.11669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
43 Khouzam RA, Molinari C, Salvi S, Marabelli M, Molinaro V, Orioli D, Saragoni L, Morgagni P, Calistri D, Ranzani GN. Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer. Oncotarget. 2017;8:18811-18820. [PMID: 27861150 DOI: 10.18632/oncotarget.13401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Stein M, Ruggiero P, Rappuoli R, Bagnoli F. Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine. Front Immunol. 2013;4:328. [PMID: 24133496 DOI: 10.3389/fimmu.2013.00328] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
46 Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018; 24(26): 2818-2832 [PMID: 30018477 DOI: 10.3748/wjg.v24.i26.2818] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 93] [Article Influence: 25.8] [Reference Citation Analysis]
47 Cancer Genome Atlas Research Network., Analysis Working Group: Asan University., BC Cancer Agency., Brigham and Women’s Hospital., Broad Institute., Brown University., Case Western Reserve University., Dana-Farber Cancer Institute., Duke University., Greater Poland Cancer Centre., Harvard Medical School., Institute for Systems Biology., KU Leuven., Mayo Clinic., Memorial Sloan Kettering Cancer Center., National Cancer Institute., Nationwide Children’s Hospital., Stanford University., University of Alabama., University of Michigan., University of North Carolina., University of Pittsburgh., University of Rochester., University of Southern California., University of Texas MD Anderson Cancer Center., University of Washington., Van Andel Research Institute., Vanderbilt University., Washington University., Genome Sequencing Center: Broad Institute., Washington University in St. Louis., Genome Characterization Centers: BC Cancer Agency., Broad Institute., Harvard Medical School., Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University., University of North Carolina., University of Southern California Epigenome Center., University of Texas MD Anderson Cancer Center., Van Andel Research Institute., Genome Data Analysis Centers: Broad Institute., Brown University:., Harvard Medical School., Institute for Systems Biology., Memorial Sloan Kettering Cancer Center., University of California Santa Cruz., University of Texas MD Anderson Cancer Center., Biospecimen Core Resource: International Genomics Consortium., Research Institute at Nationwide Children’s Hospital., Tissue Source Sites: Analytic Biologic Services., Asan Medical Center., Asterand Bioscience., Barretos Cancer Hospital., BioreclamationIVT., Botkin Municipal Clinic., Chonnam National University Medical School., Christiana Care Health System., Cureline., Duke University., Emory University., Erasmus University., Indiana University School of Medicine., Institute of Oncology of Moldova., International Genomics Consortium., Invidumed., Israelitisches Krankenhaus Hamburg., Keimyung University School of Medicine., Memorial Sloan Kettering Cancer Center., National Cancer Center Goyang., Ontario Tumour Bank., Peter MacCallum Cancer Centre., Pusan National University Medical School., Ribeirão Preto Medical School., St. Joseph’s Hospital &Medical Center., St. Petersburg Academic University., Tayside Tissue Bank., University of Dundee., University of Kansas Medical Center., University of Michigan., University of North Carolina at Chapel Hill., University of Pittsburgh School of Medicine., University of Texas MD Anderson Cancer Center., Disease Working Group: Duke University., Memorial Sloan Kettering Cancer Center., National Cancer Institute., University of Texas MD Anderson Cancer Center., Yonsei University College of Medicine., Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health. Integrated genomic characterization of oesophageal carcinoma. Nature 2017;541:169-75. [PMID: 28052061 DOI: 10.1038/nature20805] [Cited by in Crossref: 798] [Cited by in F6Publishing: 676] [Article Influence: 159.6] [Reference Citation Analysis]
48 Carvalho S, Oliveira T, Bartels MF, Miyoshi E, Pierce M, Taniguchi N, Carneiro F, Seruca R, Reis CA, Strahl S, Pinho SS. O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer. Oncotarget 2016;7:65231-46. [PMID: 27533452 DOI: 10.18632/oncotarget.11245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
49 Yin H, Song P, Su R, Yang G, Dong L, Luo M, Wang B, Gong B, Liu C, Song W, Wang F, Ma Y, Zhang J, Wang W, Yu J. DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer. Sci Rep 2016;6:18824. [PMID: 26729612 DOI: 10.1038/srep18824] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
50 Carneiro P, Moreira AM, Figueiredo J, Barros R, Oliveira P, Fernandes MS, Ferro A, Almeida R, Oliveira C, Carneiro F, Schmitt F, Paredes J, Velho S, Seruca R. S100P is a molecular determinant of E-cadherin function in gastric cancer. Cell Commun Signal 2019;17:155. [PMID: 31767037 DOI: 10.1186/s12964-019-0465-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 2013;17:1187-201. [PMID: 23957294 DOI: 10.1517/14728222.2013.827174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
52 Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585 [PMID: 25206265 DOI: 10.3748/wjg.v20.i33.11574] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
53 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16:e60-e70. [PMID: 25638682 DOI: 10.1016/s1470-2045(14)71016-2] [Cited by in Crossref: 166] [Cited by in F6Publishing: 95] [Article Influence: 23.7] [Reference Citation Analysis]
54 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
55 Li P, Shi Y, Shuai H, Cai Y, Lu W, Wang G, Gao L, Wang L, Fan X, Yang X. Alterted SLIT2/ROBO1 signalling is linked to impaired placentation of missed and threatened miscarriage in early pregnancy. Histopathology 2017;71:543-52. [DOI: 10.1111/his.13250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tasso M, Singh MK, Giovanelli E, Fragola A, Loriette V, Regairaz M, Dautry F, Treussart F, Lenkei Z, Lequeux N, Pons T. Oriented Bioconjugation of Unmodified Antibodies to Quantum Dots Capped with Copolymeric Ligands as Versatile Cellular Imaging Tools. ACS Appl Mater Interfaces 2015;7:26904-13. [PMID: 26551755 DOI: 10.1021/acsami.5b09777] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]